Current Issue
Volume 52, Number 1 January 2023
A recent resurgence of paralytic poliomyelitis (polio) cases, from vaccine-derived poliovirus (VDPV) in non-endemic countries, highlights an increased risk of re-infection from the importation and transmission of wild poliovirus and VDPV.
This review provides an update on the clinical manifestations of polio and highlights key public health interventions aimed at reducing the risk of poliovirus transmission globally.
Featured
Combating a resurgence of poliomyelitis through public health surveillance and vaccination
Vaccination and surveillance: Two basic tools for a final poliomyelitis eradication
Clinical efficacy and long-term immunogenicity of an early triple dose regimen of SARS-CoV-2...
Early COVID-19 booster is beneficial in cancer patients
Ablation therapies for paroxysmal atrial fibrillation: A systematic review and patient-level network meta-analysis
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation
Case studies of fetal mosaicisms detected by non-invasive prenatal testing
Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and...
Pharmacokinetic and pharmacogenomic considerations in managing use of nirmatrelvir-ritonavir and molnupiravir and dermatological...
Low skeletal muscle mass predicts poor prognosis of elderly patients after emergency laparotomy:...
Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore
Meeting today’s healthcare needs: Medicine at the interface
Call For Papers
The Annals is the official journal of the Academy of Medicine, Singapore. Established in 1972, Annals is the leading medical journal in Singapore which aims to publish novel findings from clinical research as well as medical practices that can benefit the medical community.
Published monthly, online, open-access and peer-reviewed, Annals is indexed in Index Medicus, Science Citation Index – Expanded, ISI Alerting Services, and Current Contents/ Clinical Medicine. Impact Factor for the Annals in 2021 is 8.713 and 5-year Impact Factor is 5.544.
The rapidly ageing population and enlarging burden of chronic diseases require a proportionate emphasis on health promotion and disease prevention. A health system that is more data-driven and patient-centric, which leverages the innovative use of technology and digital solutions, will be areas warranting research attention and coverage. The Annals invites submission of manuscripts that advance the scientific basis of clinical knowledge, and the practice of medicine in Singapore and internationally. We welcome submissions that address challenges in the management of chronic diseases (e.g. cancer, cardiovascular diseases, ageing, diabetes mellitus and neurological diseases), and use of technology and digital medicine to improve patient care.
Papers of sufficient merits will be published. Authors will also be notified if their manuscripts are deemed not suitable for publication.
